ELEKTA HAS REPURCHASED OWN SHARES FOR SEK 100 M
PRESS RELEASE
Stockholm, Sweden, July 13, 2007
During the period July 4 through July 12, 2007, Elekta has repurchased 871,600 B shares at an average price of SEK 114.73 totaling SEK 99,997,612.
Accordingly, Elekta’s current holding of own shares (treasury stock) amounts to 1,630,871 B shares, which Elekta’s Board intends to propose to the AGM to be cancelled.
These repurchases were carried out in line with the Board’s decision on July 2, 2007, to mandate the executive management to initiate repurchase of shares in an amount of SEK 100 M.
The total number of shares in Elekta (prior to cancellation of the shares now repurchased) amounts to 93,794,776.
******
For further information, please contact:
Okee Williams
Corporate Communications, Elekta AB
Tel: +46 70 600 53 64 (mobile), e-mail: okee.williams@elekta.com
About Elekta
Elekta is an international medical-technology Group, providing meaningful clinical solutions, comprehensive information systems and services for improved cancer care and management of brain disorders. All of Elekta’s solutions employ non-invasive or minimally invasive techniques and are therefore clinically effective, gentle on the patient and cost-effective.
Clinical solutions include among others Leksell Gamma Knife® for non-invasive treatment of brain disorders and Elekta Synergy® for image guided radiation therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April 2005, the Elekta Group is the world’s largest supplier of oncology software.
Elekta’s systems and solutions are used at over 4,000 hospitals around the world to treat cancer and manage clinical operations as well as to diagnose and treat brain disorders, including tumors, vascular malformations and functional disorders.
With approx. 2,000 employees, Elekta’s corporate headquarter is located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.
This information was brought to you by Cision http://newsroom.cision.com
The following files are available for download:
PDF version |